Gilead's revenue rises 17% driven by sales of coronavirus treatment remdesivir
October 28, 2020 at 17:11 PM EDT
Remdesivir generated $873 million in sales during the third quarter, mostly in the U.S., the company said.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|